- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07947849
Efficacy of Postbiotic Supplementation in Improving Antioxidant Status
Effects of Postbiotic Supplementation in Improving Total Antioxidant Status in Healthy Adults
This study will evaluate changes in salivary antioxidant capacity, oxidative stress biomarkers, and self-perceived general well-being during eight weeks of postbiotic supplementation in generally healthy adults.
Thirty-six participants aged 18 years or older will receive MettaBion Liquid twice daily for eight weeks. Assessments will be conducted before supplementation and at Weeks 4 and 8. Saliva samples will be analysed for total antioxidant capacity, malondialdehyde, 3-nitrotyrosine, and 8-hydroxy-2'-deoxyguanosine. General well-being will be assessed using a visual analogue scale.
This prospective, single-arm study will estimate within-participant changes and their variability to inform the design and sample-size planning of a future randomised, placebo-controlled trial.
연구 개요
상세 설명
This prospective, single-arm, open-label study will evaluate changes in salivary antioxidant capacity, oxidative stress biomarkers, and self-perceived general well-being following eight weeks of postbiotic supplementation in generally healthy adults. The study will recruit 36 participants aged 18 years or older. Assessments will be conducted at baseline, Week 4, and Week 8.
Participants will consume MettaBion Liquid orally for eight weeks, taking one sachet after breakfast and one sachet after dinner each day. Each sachet contains 5,000 mg of proprietary cell-free metabolite preparations derived from Lactobacillus plantarum, providing a total daily intake of 10,000 mg of the preparation. Adherence will be monitored using a participant compliance form.
Unstimulated saliva samples will be collected at each assessment visit to measure total antioxidant capacity (T-AOC), malondialdehyde (MDA), 3-nitrotyrosine (3-NT), and 8-hydroxy-2'-deoxyguanosine (8-OHdG) using Elabscience assay kits. These measurements will assess antioxidant capacity and markers of lipid peroxidation, protein nitration, and oxidative DNA damage, respectively. Participants will also assess their general well-being using a visual analogue scale ranging from 1 to 10, with higher scores indicating better perceived well-being.
The primary outcome will be the change in salivary T-AOC from baseline to Week 8. Secondary outcomes will include the change in salivary T-AOC from baseline to Week 4 and changes in salivary MDA, 3-NT, 8-OHdG, and general well-being scores from baseline to Weeks 4 and 8.
Eligible participants must be generally healthy, willing to follow the study procedures and attend follow-up visits, and able to provide written informed consent before enrolment. Individuals will be excluded if they are currently taking supplements intended to improve antioxidant status, antibiotics, antiviral medicines, or prebiotic or postbiotic supplements; have undergone major surgery within the preceding six months; or are pregnant or breastfeeding.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Chung Keat Tan, PhD
- 전화번호: +6017-5063305
- 이메일: cktan.jsci@gmail.com
연구 장소
-
-
Kuala Lumpur
-
Cheras, Kuala Lumpur, 말레이시아, 56000
- UCSI University
-
연락하다:
- Eugenie Sin Sing Tan, PhD
- 전화번호: +6016-8924008
- 이메일: eugenietan@ucsiuniversity.edu.my
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Generally healthy adults aged 18 years or older.
- Willing to follow the study plan and attend follow-up visits.
- Willing to provide written informed consent before enrolment.
Exclusion Criteria:
- Currently taking supplements intended to improve antioxidant status.
- Currently taking antibiotics or antiviral medicines.
- Currently taking prebiotic or postbiotic supplements.
- Major surgery within the previous six months.
- Pregnant or breastfeeding.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: MettaBion Liquid Supplementation
Participants will consume one sachet of MettaBion Liquid after breakfast and one sachet after dinner daily for eight weeks. Each sachet contains 5,000 mg of proprietary cell-free metabolite preparations derived from Lactobacillus plantarum. |
5,000 mg of proprietary cell-free metabolite preparations derived from Lactobacillus plantarum. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in salivary total antioxidant capacity from baseline to Week 8
기간: Baseline and Week 8
|
Change in salivary total antioxidant capacity measured using an Elabscience assay kit. |
Baseline and Week 8
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in salivary malondialdehyde
기간: Baseline and Week 8
|
Change in salivary malondialdehyde, a marker of lipid peroxidation, measured using an Elabscience assay kit. |
Baseline and Week 8
|
|
Change in salivary 3-nitrotyrosine
기간: Baseline and Week 8
|
Change in salivary 3-nitrotyrosine, a marker of protein nitration, measured using an Elabscience assay kit. |
Baseline and Week 8
|
|
Salivary 8-hydroxy-2'-deoxyguanosine (8-OHdG)
기간: Baseline and Week 8
|
Change in salivary 8-hydroxy-2'-deoxyguanosine, a marker of oxidative DNA damage, measured using an Elabscience assay kit. |
Baseline and Week 8
|
|
Self-perceived general well-being
기간: Baseline, Week 4, and Week 8
|
Change in self-perceived general well-being assessed using a visual analogue scale ranging from 1 to 10, with higher scores indicating better general well-being. |
Baseline, Week 4, and Week 8
|
공동 작업자 및 조사자
협력자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- METTABION - ANTIOXIDANT
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
De-identified individual participant data underlying the published results will be made available to qualified researchers upon reasonable request to the principal investigator. Access will be subject to review of the proposed research purpose, consistency with participant consent and institutional ethics requirements, and a signed data use agreement.
IPD 공유 기간
Beginning six months after publication of the study results and continuing for five years.
IPD 공유 액세스 기준
Researchers must submit a methodologically sound proposal outlining the intended use of the data to the principal investigator.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .